Search Orphan Drug Designations and Approvals
-
Generic Name: | Marzeptacog alfa (activated) |
---|---|
Date Designated: | 12/15/2021 |
Orphan Designation: | Treatment of Bleeding Episodes in Patients with Hemophilia A or B, Including those with Inhibitors |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
GC Biopharma Corp. 107 Ihyeon-ro 30 beong-gil, Giheung-gu Yongin-si, Gyeonggi-do South Korea The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-